Health Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Absorption Systems
FDA Awards Absorption Systems Phase I SBIR Grant for CellPort Technologies™
February 27th, 2009
Absorption Systems, LP, announced that the company has been awarded a Small Business Innovation Research (SBIR) Phase I grant from the U.S. Food and Drug Administration (FDA) to develop an innovative tool to help determine the potential for drug-drug interactions. Absorption Systems will use the $215,000 Phase I grant to further develop the company’s CellPort Technologies™ assay system, a suite of preclinical in vitro test systems designed to provide definitive data regarding interactions between new drugs under investigation and specific transporter proteins that have been identified by the FDA as key indicators of drug safety. The current suite of CellPort Technologies test systems...
Source: Health Business Week (2009-02-27)
|
